Patient P-01764

Synthetic patientNBL-101 · Day 119 · 25–34 · M · baseline S08Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

12%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S08

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Toxicity-11
GI instability+8
Treatment adherence+7
Inflammatory activity-3

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

7.9/100

improving · -2.9 vs previous 14 d

Toxicity

Blood

9.4/100

worsening · +1.0 vs previous 14 d

Sleep quality

Wearable

54.5/100

improving · +3.3 vs previous 14 d

Energy level

Daily log

6.8/10

stable · 0.0 vs previous 14 d

Stress level

Daily log

2.5/10

stable · -0.1 vs previous 14 d

Steps

Wearable

5,469

worsening · -281 vs previous 14 d

Adherence

Companion

98.5 %

stable · +1.2 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 93 from the failing basin, 14 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
-1.3no signal · 32%
Spicy / capsaicin
-1.2no signal · 28%
Dietary fat load
+1no signal · 23%
Insoluble fibre
-1no signal · 22%
Histamine load
-0.1no signal · 15%
Simple carbohydrates
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Autonomic recovery ↑20
- WearableShort sleep window

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.2 · butyrate capacity 68/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiNormal
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 66 ms
Sleep: 6.1 h
Steps: 6,326
Resting HR: 64 bpm

Daily log: GI score 8, nutritional resilience 73, adherence 99.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01467	49%	S09	HY-01	improved	79
P-01439	46%	S18	ME-01	improved	79
P-01625	45%	S06	SC-12	improved	83
P-01329	43%	S08	BR-03	improved	79
P-01671	39%	S04	SC-12	improved	90
P-01654	37%	S08	CR-01	improved	85
P-01796	37%	S09	SC-12	improved	86
P-01798	36%	S08	NP-02	improved	78
P-01479	35%	S15	DT-01	improved	84
P-01791	34%	S06	ME-01	improved	79
P-01855	34%	S04	DT-01	improved	73
P-01724	33%	S10	DT-01	improved	63